We are live on ! Find out more
MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

12 hedge funds and large institutions have $1.26M invested in Stealth BioTherapeutics Corp. ADS in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less funds holding

Funds holding: 13 → 12 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

65% less capital invested

Capital invested by funds: $3.62M → $1.26M (-$2.36M)

Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$123K
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$31.7K
3
SBL
Sargent Bickham Lagudis
Colorado
+$20.5K
4
PAM
PVG Asset Management
Colorado
+$16.7K
5
UBS Group
UBS Group
Switzerland
+$14.7K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$1.12M
2
SM
Sabby Management
Florida
-$473K
3
IC
Ikarian Capital
Texas
-$419K
4
Citadel Advisors
Citadel Advisors
Florida
-$177K
5
Squarepoint
Squarepoint
New York
-$100K
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
$761K -$419K -300,000 -38%
Goldman Sachs
2
Goldman Sachs
New York
$138K +$123K +88,426 New
Renaissance Technologies
3
Renaissance Technologies
New York
$128K -$1.12M -799,469 -91%
BFM
4
Boothbay Fund Management
New York
$90K -$49.6K -35,561 -38%
Two Sigma Advisers
5
Two Sigma Advisers
New York
$35K +$31.7K +22,700 New
HF
6
HRT Financial
New York
$27K -$698 -500 -3%
UBS Group
7
UBS Group
Switzerland
$24K +$14.7K +10,537 +221%
SBL
8
Sargent Bickham Lagudis
Colorado
$23K +$20.5K +14,714 New
PAM
9
PVG Asset Management
Colorado
$18.7K +$16.7K +11,988 New
Morgan Stanley
10
Morgan Stanley
New York
$9K -$10.7K -7,661 -56%
Osaic Holdings
11
Osaic Holdings
Arizona
$4K +$1.2K +859 +61%
BBHC
12
Brown Brothers Harriman & Co
New York
$273 – – –
SM
13
Sabby Management
Florida
– -$473K -301,575 Closed
Citadel Advisors
14
Citadel Advisors
Florida
– -$177K -112,439 Closed
Squarepoint
15
Squarepoint
New York
– -$100K -63,729 Closed
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
– -$40K -25,264 Closed
SFS
17
Sowell Financial Services
Arkansas
– -$5K -2,939 Closed

MITO Hedge Fund Activity: Q2 2021 in Review

12 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q2 2021, worth a combined $1.26M — down 65% from $3.62M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of MITO and 4 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 2 added.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $123K. The largest seller was Renaissance Technologies, cutting an estimated $1.12M.

  • 12 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q2 2021, down from 13 in Q1 2021.
  • Funds reported $1.26M of Stealth BioTherapeutics Corp. ADS stock for Q2 2021, down 65% quarter-over-quarter.
  • 4 funds opened new Stealth BioTherapeutics Corp. ADS positions in Q2 2021 and 5 closed out, a net change of -1 holder.
  • The largest Stealth BioTherapeutics Corp. ADS buyer in Q2 2021 was Goldman Sachs, an estimated $123K added.
  • The largest Stealth BioTherapeutics Corp. ADS seller in Q2 2021 was Renaissance Technologies, an estimated $1.12M sold.

Based on aggregated 13F filings for Q2 2021.